UNH price forecast: More downside ahead? UnitedHealth slips near $360

Traders Union
All News
Financial News
Unitedhealth group slips 1.31% today

Highlights

UnitedHealth Group (UNH) trades at $360.86, above its 20-day and 50-day moving averages, but remains below the 200-day average of $393.08.
UNH is forecast to report Q3 2025 EPS of $2.84, a 60.3% year-over-year decline, alongside a 12.5% revenue rise to $113.38 billion.
Technical signals show strong buying momentum but overall trend indecision, with UNH likely to trade sideways between $358.69 and $363.08 amid ongoing volatility.

Margin pressure risks grow as earnings slump offsets revenue gains

UnitedHealth Group is expected to report Q3 2025 earnings per share of $2.84, representing a sharp 60.3% year-over-year decline, while revenue is anticipated to increase by 12.5% to $113.38 billion. This earnings release will be closely watched for signs of margin pressures and ongoing business challenges. The outlook remains affected by uncertainty around medical cost trends and recent leadership changes.

Mixed momentum and oscillator signals highlight trend uncertainty

Dynamic support for UNH lies near the Ichimoku Kijun at $354.41, with resistance at the psychological $365 level or the 200-day moving average. The MACD on the daily chart signals strong buying, but a low ADX reading points to trend indecision. Daily RSI and CCI continue to support buying, while Stoch RSI is neutral and short-term readings show pockets of oversold. Bull Power favors buyers, while the Awesome Oscillator reflects strong selling on a down day. The session opened with a small gap down and current prices sit near the lower end of a $358.08–$363.27 range, with moderate volatility and sustained selling pressure. The divergence between momentum and oscillator indicators signals uncertainty, with negative price action contradicting short-term bullish signals.

Sideways trade expected as upside probability remains subdued

In the short term, UNH is likely to trade sideways between $358.69 and $363.08, with an average price near $360.89. The probability of a price increase is low at less than 20%, as only weekly RSI and ADX point to potential strength, while MACD and the MA-50 on the weekly chart indicate a bearish setup. The bullish scenario would require a break above $363–$365 resistance with stronger momentum, while a close below $358 increases the risk of further declines.

Anton Kharitonov, expert at Traders Union, sees UnitedHealth Group trading in a technically conflicted setup, where short-term bullish signals are offset by persistent longer-term resistance and negative price action. He notes that fundamentals remain weak, with a projected 60.3% year-over-year EPS decline and margin risks amplified by industry uncertainties and recent management changes. Base case remains rangebound between $358.69 and $363.08, with little reason for near-term optimism until stronger momentum appears. "Unless we see a decisive break above $365, I remain defensive and would not chase the current upside setup."

Previously it was noted that bullish momentum diverges from overbought signals amid increased volatility in UNH shares. At that time, investors were relying on technical signals due to muted news flow and ongoing market uncertainty, as described in the discussion about bullish momentum diverges from overbought signals.

Source of Data: UNH Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.